Bill tracker, S. 1041, Commerce

Affordable Prescriptions for Patients Act

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the Senate
  5. Passed the House
  6. To the President
  7. Became law

Introduced Mar 13, 2025 with 3 cosponsors. Latest action Jul 21, 2026: Held at the desk.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentAprJulOct2026AprJulMar 13, 2025: Introduced in SenateMar 13, 2025: Read twice and referred to the Committee on the Judiciary.Apr 3, 2025: Committee on the Judiciary. Ordered to be reported with amendments favorably.Apr 10, 2025: Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.Apr 10, 2025: Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.Jul 21, 2026: Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.Jul 21, 2026: Passed Senate with amendments by Unanimous Consent. (consideration: CR S4198-4199; text: CR S4199)Jul 21, 2026: Message on Senate action sent to the House.Jul 21, 2026: Received in the House.Jul 21, 2026: Held at the desk.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Related bills

Full history

    • House. Held at the desk.
    • House. Received in the House.
    • Senate. Message on Senate action sent to the House.
    • Passed the SenateSenate. Passed Senate with amendments by Unanimous Consent. (consideration: CR S4198-4199; text: CR S4199)
    • Passed the SenatePassed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.
    • On the calendarSenate. Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.
    • ReportedCommittee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
    • Committee approvedSenate. Committee on the Judiciary. Ordered to be reported with amendments favorably.
    • ReferredSenate. Read twice and referred to the Committee on the Judiciary.
    • IntroducedIntroduced in Senate

Subjects

Civil actions and liabilityCompetition and antitrustConsumer affairsDrug safety, medical device, and laboratory regulationHealth care costs and insuranceInflation and pricesIntellectual propertyJudicial review and appealsManufacturingPrescription drugs

Read the bill on Congress.gov